62
Participants
Start Date
May 3, 2017
Primary Completion Date
December 21, 2018
Study Completion Date
December 21, 2018
Dapagliflozin Tablet
Daily oral administration of dapagliflozin with dietary counseling to promote weight loss. Dapagliflozin 5 mg tablet will begin as one tablet per day for the first 14-days. In the absence of complications, side effects, or unfavorable reactions, the dose will then increase to two tablets for the remainder of the study.
Placebo Tablet
Daily administration of placebo tablet with dietary counseling to promote weight loss. Matching placebo for dapagliflozin 5 mg tablet will begin as one tablet per day for the first 14-days. In the absence of complications, side effects, or unfavorable reactions, the dose will then increase to two tablets for the remainder of the study.
Colorado State University, Dept. of Health and Exercise Science, Fort Collins
Collaborators (1)
AstraZeneca
INDUSTRY
Christopher Bell
OTHER